Iqvia Holdings Inc (NYSE:IQV) insider James H. Erlinger III sold 10,000 shares of the business’s stock in a transaction dated Wednesday, January 17th. The stock was sold at an average price of $99.97, for a total transaction of $999,700.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Iqvia Holdings Inc (NYSE IQV) traded up $2.58 during midday trading on Monday, reaching $98.63. 1,258,340 shares of the company’s stock were exchanged, compared to its average volume of 1,138,950. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 1.29. The company has a market cap of $19,980.00, a P/E ratio of 340.10, a P/E/G ratio of 1.31 and a beta of 0.61. Iqvia Holdings Inc has a 52-week low of $75.94 and a 52-week high of $110.67.
Several analysts recently commented on the stock. Morgan Stanley lifted their target price on shares of Iqvia from $96.00 to $121.00 and gave the stock an “overweight” rating in a report on Thursday, November 9th. Zacks Investment Research raised shares of Iqvia from a “hold” rating to a “buy” rating and set a $114.00 target price for the company in a report on Saturday, October 21st. Barclays lifted their target price on shares of Iqvia from $100.00 to $120.00 and gave the stock an “overweight” rating in a report on Friday, October 27th. Stifel Nicolaus raised shares of Iqvia from a “hold” rating to a “buy” rating and lifted their target price for the stock from $92.00 to $128.00 in a report on Friday, October 27th. Finally, Mizuho set a $97.00 target price on shares of Iqvia and gave the stock a “hold” rating in a report on Wednesday, January 24th. Seven analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $109.71.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Winslow Evans & Crocker Inc. bought a new stake in Iqvia in the 4th quarter valued at about $123,000. Valeo Financial Advisors LLC acquired a new position in shares of Iqvia in the 4th quarter valued at approximately $170,000. IFP Advisors Inc acquired a new position in shares of Iqvia in the 4th quarter valued at approximately $200,000. Livforsakringsbolaget Skandia Omsesidigt acquired a new position in shares of Iqvia in the 4th quarter valued at approximately $209,000. Finally, Atria Investments LLC acquired a new position in shares of Iqvia in the 4th quarter valued at approximately $218,000. 95.91% of the stock is owned by hedge funds and other institutional investors.
Iqvia Company Profile
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.